Jomehpour H, Pouriran M, Heydari Yazdi A, Baghban Haghighi M, Dastgheib M, Omidvar-Tehrani S
Addict Health. 2023; 14(4):256-262.
PMID: 37559787
PMC: 10408755.
DOI: 10.34172/ahj.2022.1334.
Namchuk A, Lucki I, Browne C
Adv Drug Alcohol Res. 2022; 2.
PMID: 36177442
PMC: 9518754.
DOI: 10.3389/adar.2022.10254.
Cox J, Sherva R, Lunetta K, Saitz R, Kon M, Kranzler H
Explor Med. 2021; 1(1):27-41.
PMID: 33554217
PMC: 7861053.
DOI: 10.37349/emed.2020.00003.
LeSaint K, Ho R, Heard S, Smollin C
J Med Toxicol. 2020; 17(2):190-196.
PMID: 33078365
PMC: 8017020.
DOI: 10.1007/s13181-020-00816-1.
Genberg B, Astemborski J, Treisman G, Anagnostopoulos A, Mehta S, Kirk G
J Subst Abuse Treat. 2019; 106:107-112.
PMID: 31540605
PMC: 6800030.
DOI: 10.1016/j.jsat.2019.09.001.
The relationship between treatment accessibility and preference amongst out-of-treatment individuals who engage in non-medical prescription opioid use.
Huhn A, Tompkins D, Dunn K
Drug Alcohol Depend. 2017; 180:279-285.
PMID: 28942031
PMC: 5648596.
DOI: 10.1016/j.drugalcdep.2017.08.019.
Predictors of buprenorphine treatment success of opioid dependence in two Baltimore City grassroots recovery programs.
Damian A, Mendelson T, Agus D
Addict Behav. 2017; 73:129-132.
PMID: 28505488
PMC: 5789789.
DOI: 10.1016/j.addbeh.2017.05.010.
Long-term retention in Office Based Opioid Treatment with buprenorphine.
Weinstein Z, Kim H, Cheng D, Quinn E, Hui D, Labelle C
J Subst Abuse Treat. 2017; 74:65-70.
PMID: 28132702
PMC: 5312773.
DOI: 10.1016/j.jsat.2016.12.010.
Failure to get into substance abuse treatment.
Fisher D, Reynolds G, DAnna L, Hosmer D, Hardan-Khalil K
J Subst Abuse Treat. 2016; 73:55-62.
PMID: 28017185
PMC: 5193166.
DOI: 10.1016/j.jsat.2016.11.004.
Factors associated with interest in receiving prison-based methadone maintenance therapy in Malaysia.
Mukherjee T, Wickersham J, Desai M, Pillai V, Kamarulzaman A, Altice F
Drug Alcohol Depend. 2016; 164:120-127.
PMID: 27207155
PMC: 5592792.
DOI: 10.1016/j.drugalcdep.2016.04.037.
Predictors of buprenorphine initial outpatient maintenance and dose taper response among non-treatment-seeking heroin dependent volunteers.
Woodcock E, Lundahl L, Greenwald M
Drug Alcohol Depend. 2014; 146:89-96.
PMID: 25479914
PMC: 4272885.
DOI: 10.1016/j.drugalcdep.2014.11.016.
Cannabis use history and characteristics of quit attempts: a comparison study of treatment-seeking and non-treatment-seeking cannabis users.
Pacek L, Vandrey R
Exp Clin Psychopharmacol. 2014; 22(6):517-23.
PMID: 25150537
PMC: 4250402.
DOI: 10.1037/a0037791.
Baseline characteristics and treatment outcomes in prescription opioid dependent patients with and without co-occurring psychiatric disorder.
Griffin M, Dodd D, Potter J, Rice L, Dickinson W, Sparenborg S
Am J Drug Alcohol Abuse. 2013; 40(2):157-62.
PMID: 24219166
PMC: 3947491.
DOI: 10.3109/00952990.2013.842241.
The association between self-reported mental health status and alcohol and drug abstinence 5 years post-assessment for an addiction disorder in U.S. and Swedish samples.
Trocchio S, Chassler D, Storbjork J, Delucchi K, Witbrodt J, Lundgren L
J Addict Dis. 2013; 32(2):180-93.
PMID: 23815425
PMC: 3854960.
DOI: 10.1080/10550887.2013.795468.
Perceived child behavior problems, parenting stress, and maternal depressive symptoms among prenatal methamphetamine users.
Liles B, Newman E, Lagasse L, Derauf C, Shah R, Smith L
Child Psychiatry Hum Dev. 2012; 43(6):943-57.
PMID: 22552952
PMC: 3717339.
DOI: 10.1007/s10578-012-0305-2.
Psychopathy Among Mexican American Gang Members: A Comparative Study.
Valdez A, Kaplan C, Codina E
Int J Offender Ther Comp Criminol. 2011; 44(1):46-58.
PMID: 21516257
PMC: 3080033.
DOI: 10.1177/0306624X00441005.
Meta-analysis of depression and substance use and impairment among cocaine users.
Conner K, Pinquart M, Holbrook A
Drug Alcohol Depend. 2008; 98(1-2):13-23.
PMID: 18585871
PMC: 2570759.
DOI: 10.1016/j.drugalcdep.2008.05.005.
Factors influencing the course of opiate addiction.
Scherbaum N, Specka M
Int J Methods Psychiatr Res. 2008; 17 Suppl 1:S39-44.
PMID: 18543361
PMC: 6879067.
DOI: 10.1002/mpr.244.
Meta-analysis of depression and substance use and impairment among intravenous drug users (IDUs).
Conner K, Pinquart M, Duberstein P
Addiction. 2008; 103(4):524-34.
PMID: 18261192
PMC: 4864591.
DOI: 10.1111/j.1360-0443.2007.02118.x.
Satisfaction with life and opioid dependence.
Luty J, Rajagopal Arokiadass S
Subst Abuse Treat Prev Policy. 2008; 3:2.
PMID: 18226241
PMC: 2259341.
DOI: 10.1186/1747-597X-3-2.